Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation

NCT03178695 is registered in ClinicalTrials.gov with Ascendance Biomedical as lead sponsor.

NCT NCT03178695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03178695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation
Lead sponsor
Ascendance Biomedical
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2017
Completion date
May 1, 2018
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, infertility unexplained, infertility, female, menopause, menopause premature asymptomatic, menopause premature symptomatic, menopause related conditions, menopause, premature, perimenopausal disorder, premature ovarian failure, premature ovarian failure 1, premature ovarian failure 2a, premature ovarian failure 3, premature ovarian failure 4, premature ovarian failure 5, premature ovarian failure 6, premature ovarian failure 7, premature ovarian failure 8, premature ovarian failure 9, premature ovarian failure, familial